FERMISCAN HOLDINGS LIMITED (FER)

name changed to Tempo Australia Ltd (TPP)

we understand that on or about this date the company consolidated its shares 1 for 10

The securities of Fermiscan Holdings Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, following the receipt of shareholder approval for the proposed acquisition of Industry Partners Pty Ltd and Immigration Partners Pty Ltd. In accordance with ASX" requirements for compliance with Chapter 11 of the Listing Rules, the Company" securities will remain suspended until the Company has complied with Chapters 1 and 2 of the Listing Rules

the suspension of trading in the securities of Fermiscan Holdings Limited (the "Company") will be lifted immediately, following the Company's compliance with Chapter 12 of the ASX Listing Rules

company advises that as a result of the terms of the convertible note issue being satisfied that the convertible notes have converted and as a result the 150,000,000 ordinary shares have been issued to the note holders

the Directors of the company advise that the rights issue closed as provided in the prospectus at 5.00pm (Sydney time) 3 March 2011. $75,429.89 was received with subscriptions for 7,542,989 shares. There have been further subscriptions for 16,100,000 shares under the shortfall facility with $161,000 received. Additionally there have been 9 late applications for an additional 354,525 shares, with $3,545.25 received, such applications will be dealt with under the shortfall facility. It is noted that the prospectus provides that the shortfall facility remains open for three (3) months past the closure of the offer. The Directors have resolved that applications for shares under the shortfall facility will be dealt with on a first come first served basis

company confirms that dispatch of the non-renounceable Rights Issue Replacement Prospectus dated 10 February 2011 together with personalised Entitlement and Acceptance Forms has been completed today

issues Replacement Prospectus

Fermiscan has formed the view that it is unreasonable to extend the Rights Issue to shareholders outside of Australia, and that the offer pursuant to the Rights Issue will only be extended to Fermiscan shareholders on record at 5pm 14 February 2011 with registered addresses within Australia

Fermiscan Holdings Limited (Fermiscan or Company) (ASX:FER) today lodged a prospectus with ASX regarding a Non-Renounceable Rights Issue (Rights Issue) to raise up to approximately $767,533. Under the Rights Issue, eligible shareholders will be invited to subscribe for 1 new share for every 2 shares held at the record date at an offer price of $0.01 per share (the Prospectus and Entitlement and Acceptance Form pursuant to the Non- Renounceable Rights Issue will be mailed to shareholders on 17 February 2011. The closing date for acceptance is 3 March 2011)

releases a Non-Renounceable Issue Prospectus

enters into a MOU to continue Synchrotron trials

releases Half Yearly Report

all resolutions at today's AGM were passed on a show of hands

a rights issue (to raise $767k) is coming up

releases Notice of Annual General Meeting

plans the AGM for 30 Nov

releases Full Year Accounts

expects reinstatement to quotation to be 6 to 8 weeks away

provides update - it expects to make an announcement regarding a restructuring in due course

responds to ASX queries

Deed of Company Arrangement was terminated today

the sale of the intellectual property and certain assets for the sum of $250,000 plus GST to SBC Research Pty Limited, an unrelated third party, has now been settled

Deed of Company Arrangement is released

the Deed of Company Arrangement was executed today

releases Preliminary Final Report

creditors resolve that the company execute a Deed of Company Arrangement

administrator is assessing a number of offers for the assets of the company or to invest in the company

the administrator's report to creditors is available at www.woodgate.com.au

Giles Geoffrey Woodgate of Woodgate & Co., Chartered Accountant, is appointed administrator - this never augurs well for shareholders but it will be several weeks before the administrator acquaints the market with the financial position - shareholders should be aware that they may crystallise a capital loss if they wish by utilising our online worthless shares facility

Fermiscan advised in May 2009 and in June 2009 of litigation with Dr James, the inventor of the Fermiscan patent "Using hair to Screen for Breast Cancer". Dr James had filed a new patent using x-ray diffraction of fingernails and skin instead of hair for the detection of breast cancer. Fermiscan had received advice that the new patent is the property of Fermiscan and was pursuing the matter Court. On 29 May 2009, in the original hearing, the Judge handed down his judgment which was that Dr James was not obliged to transfer that new patent to Fermiscan, and awarded costs against Fermiscan. Fermiscan appealed this decision and today the New South Wales Court of Appeal dismissed with costs the Fermiscan appeal in relation to the new patents. The board expects the exposure to Dr James for costs on both the original hearing and the appeal could aggregate in excess of $500,000. The board is taking advice and considering the implications of this court decision

the securities of Fermiscan Holdings Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending an announcement with regard to the completion of an agreement in relation to the Company's business

shares reinstated to quotation

name changed from Olympus Resources Limited